January 23, 2017 5:54 AM ET

Biotechnology

Company Overview of Civitas Therapeutics, Inc.

Key Executives for Civitas Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Glenn V. Batchelder 16 RelationshipsCo-Founder, Consultant and Director54
Jeff Elton 1 RelationshipsCo-Founder--
Martin I. Freed M.D.10 RelationshipsCo-Founder and Chief Medical Officer55
Jennifer Fujii Ph.D.No RelationshipsCo-Founder--
James L. Wright Ph.D.14 RelationshipsCo-Founder and Chairman of Scientific & Clinical Advisory Board68
View More Key Executives

Civitas Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Timothy S. Nelson 14 RelationshipsMAP Pharmaceuticals, Inc.53
Glenn V. Batchelder 16 RelationshipsCivitas Therapeutics, Inc.54
James L. Wright Ph.D. 14 RelationshipsCivitas Therapeutics, Inc.68
Timothy M. Shannon M.D. 76 RelationshipsCanaan Partners57
Blair C. Jackson 22 RelationshipsAlkermes plc43
View All Board Members

Civitas Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.James L. Wright14 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
373.5K
Bonus
261.6K
Total Short Term Compensation
469.3K
Total Value of Options
34.4M
Compensation as of Fiscal Year
Civitas Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Dimension Therapeutics, Inc. Elects John Hohneker to the Board of Directors
January 20, 2017 9:31 PM ET
T2 Biosystems, Inc. Announces Resignation of Joshua Bilenker as Class II Director and from Nominating and Corporate Governance Committee
January 20, 2017 9:01 PM ET
Luminor Medical Technologies Inc. Appoints Daniel Cloutier to the Board of Directors
January 20, 2017 1:04 PM ET
Jiangsu Sihuan Bioengineering Co., Ltd Announces Executive Changes
January 20, 2017 4:31 AM ET
Polynovo Limited Appoints Gavin Smith as Joint Company Secretary
January 20, 2017 1:12 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Civitas Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.